Pediatric Vaccines

This COVID-19 roundup includes coverage of the FDA’s recent approval of bivalent booster vaccines for younger age groups, the use of COVID-19 PrEP and associated risk for the virus, an increase of...

Despite most pertussis cases occurring in infants aged 2 months or younger, this patient population is too young to receive the childhood pertussis vaccine series. The approval of the pertussis vaccine...

An updated report for the use of the influenza vaccine and antiviral medications has been released from the American Academy of Pediatrics for the 2022-2023 influenza season.

The researchers sought to better understand the public health impact of immunization in children aged 10 years or younger in the United States.

The US Food and Drug Administration has approved a new option for immunization against measles, mumps, and rubella.

This COVID-19 roundup includes coverage of the FDA’s latest emergency use authorization for vaccination in new pediatric populations, the risk of myocarditis following hospitalization, and the duration of...

In this COVID-19 roundup, we discuss a fourth COVID-19 vaccine dose, how vaccination impacts women’s menstrual cycles, a multivariant COVID-19 booster, and updates on recommendations for pediatric COVID-19...

The World Health Organization has released a new recommendation on preventive measures against malaria infection and transmission for at-risk children.

Researchers investigated whether measles-mumps-rubella and varicella vaccines separately or combined vaccination affected the incidence of pediatric herpes zoster.

Rates of childhood vaccinations have decreased since the start of the COVID-19 pandemic, according to an analysis from the Centers for Disease Control and Prevention.